The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy of cetuximab plus platinum agent in advanced, triple-negative breast carcinoma: Results of a retrospective analysis.
P. Rivera
No relevant relationships to disclose
T. Filleron
No relevant relationships to disclose
L. Gladieff
No relevant relationships to disclose
J. Delord
No relevant relationships to disclose
E. Mery
No relevant relationships to disclose
H. Roche
No relevant relationships to disclose
F. Dalenc
No relevant relationships to disclose